Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mayo Clinic supplement search

This article was originally published in The Tan Sheet

Executive Summary

Information on 105 supplements will be available by the end of the year through new "drugs and supplements" search tab added to the Mayo Clinic 1website, Rochester, Minn.-based organization announces June 10. The new search tool currently contains information on 86 herbs, vitamins and other supplements compiled by the international research collaboration Natural Standard. Consumers can search by supplement name or browse alphabetical index to find information such as the useable parts of each herb, summarized results of scientific studies testing supplement efficacy, a grading scale that rates the strength of scientific evidence and possible allergic effects of the supplement...

Information on 105 supplements will be available by the end of the year through new "drugs and supplements" search tab added to the Mayo Clinic 1 website, Rochester, Minn.-based organization announces June 10. The new search tool currently contains information on 86 herbs, vitamins and other supplements compiled by the international research collaboration Natural Standard. Consumers can search by supplement name or browse alphabetical index to find information such as the useable parts of each herb, summarized results of scientific studies testing supplement efficacy, a grading scale that rates the strength of scientific evidence and possible allergic effects of the supplement....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096935

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel